about
Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.Diagnostic value of blood thiamine metabolites in Alzheimer's disease examined by 11C-PiB PET scanningPlasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults.A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood.Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia.Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's DiseaseApplying fluid biomarkers to Alzheimer's disease.Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts.Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer's Disease and Related Disorders.Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease.Serum tau and neurological outcome in cardiac arrest.Increased levels of plasma total tau in adult Down syndrome.Tauopathies: Mechanisms and Therapeutic Strategies.A Panel of Autoantibodies Against Neural Proteins as Peripheral Biomarker for Pesticide-Induced Neurotoxicity.Tau Diagnostics and Clinical Studies.Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery: Results From the CAPACITY and ARCADIAN Studies.Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.The Past and the Future of Alzheimer's Disease Fluid Biomarkers.Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.Molecular biomarkers of Alzheimer's disease: progress and prospects.Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study.Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findingsPlasma Markers of Neurodegeneration Are Raised in Friedreich’s AtaxiaProteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
P2860
Q33576727-A06D8593-8096-4EAE-A139-D755D3E01381Q33827082-0AAFAE1F-05E7-4D26-A07A-1CA759EC3A88Q37681181-F6FD6F1E-259C-46D5-BD3C-0191A1921786Q38653401-037F7AFA-4C91-419C-A705-0A7780167697Q38669241-E6088638-C53A-4C2E-85F9-B44C6C2F96CFQ38760663-40B62B80-BD51-40B6-90F7-8D8EA625267FQ39251035-2EE6DEE8-5C20-42B6-A4D5-1A37E6504EAAQ39451611-45F73236-FC23-4889-B794-18A4B1B3AA50Q40129154-17C793C1-335E-441E-B91E-52479AF7DFEEQ41097447-43D595C3-97E7-409A-B41F-9EF77BFF1047Q41534154-AB77FF7B-2105-417E-B419-210FAD32938FQ41571333-C566B5DB-F8D3-4160-B23A-A79CFE075A93Q41600844-072983D6-D32E-467C-A9EE-966A26865BF2Q42335462-55666696-E435-4C91-BFFE-A4BE835019C3Q44359436-1AF1117A-FAC8-4C75-8644-24D4E9B749C0Q47093805-E2145FC3-F668-4586-B353-0B61B83000A3Q47143134-95517C55-EEBA-4DCC-9502-31616039F31BQ47253592-7FDC2C9A-9AE2-4F05-AC30-C9F368DB7000Q47850611-F10FD540-40B2-4CA9-909D-5E8E879AFC29Q47870437-8EC9CD26-E2D1-4299-8257-396A9F8726DDQ47942128-DFA3523D-43AC-4D22-BAE6-B2B4CEBD8FFFQ48243501-0601A7CD-C22F-47D7-BFFE-50ABD6FC5531Q49828276-57BAE4DA-A4FB-41C1-9A15-424A60100EE9Q52594155-ADAB81EB-D22C-494D-A5A5-0607C8EAAC13Q52598834-B2B4E1FD-B702-4370-BAB5-D37DA8D98C18Q52644601-661EBB73-85EC-4AA0-92BA-72903A6BF0A9Q52682490-7CCF6494-3481-4660-824B-2BA9B195B99AQ54946040-FF9B8CF5-6D72-4C73-80B3-8647AB285536Q54980572-71BBB6B2-53D5-444C-A36F-595ECFCE485AQ54988549-1FBC70AD-DAE6-43EF-988D-D3D52CD67BFCQ58694906-64444A4E-26D1-47D2-9A4F-7C901E1DE812Q58697859-24DD99C8-AB7B-4C19-A98F-37159A664AE3Q58779295-BA96FBB4-D1D5-49F2-9F1B-E4A7DBC3EBD2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma tau in Alzheimer disease.
@en
Plasma tau in Alzheimer disease.
@nl
type
label
Plasma tau in Alzheimer disease.
@en
Plasma tau in Alzheimer disease.
@nl
prefLabel
Plasma tau in Alzheimer disease.
@en
Plasma tau in Alzheimer disease.
@nl
P2093
P2860
P50
P1433
P1476
Plasma tau in Alzheimer disease.
@en
P2093
ADNI Investigators
Andreas Jeromin
Cristina A Tan Hehir
David Baker
David Hanlon
Erik Stomrud
Leslie M Shaw
Linan Song
Philip S Insel
Sebastian Palmqvist
P2860
P304
P356
10.1212/WNL.0000000000003246
P407
P577
2016-09-30T00:00:00Z